Manus Aktteva
We are only a phone call away, Call us on: +91 79 65123395
+91 79 26463395
Home
About Us Pharmaceutical Ingredients, Active Pharmaceutical Rawmaterials, API, Intermediate, Nutraceuticals, Intermediates, Speciality chemicals, Advance level intermediatesEventsNewsEnquiryContact UsResources
Dacarbazine, 4342-03-4, BP, USP, from a WHO GMP plant with the Drug Master File, Open Part DMF and DMF in CTD Format also can be made available on request
Products A to Z
       
Search The Site
Please enter all or part of your keyword to retrive data
Search by: Chemical Name
  CAS#
  Molecular Formula
Quick Help
Services
Queries
Tel1: +91 79 65123395
Tel2: +91 79 26463395
Email: click here
Twitter  Facebook
Dacarbazine
Dacarbazine
Dacarbazine is an antineoplastic chemotherapy drug used in the treatment of various cancers, among them malignant melanoma and Hodgkin lymphoma. Antineoplastic drugs are drugs which interfere with cell growth and impede the formation of new tissue - in this case, tumor tissue. These drugs are also known as cytotoxic drugs. Dacarbazine belongs to the family of chemicals known as alkylating agents.
Product Reference ID: MA-MK-1014-D
Dacarbazine, 4342-03-4
Chemical Name: 5-(3,3-Dimethyl-1-triazenyl)imidazole-4-carboxamide
Description
CAS number 4342-03-4
Synonym 5-(3,3-Dimethyl-1-triazenyl)imidazole-4-carboxamide
Molecular Formula C6H10N6O
Molecular Weight 182.18
Specifications BP, USP
Packing Export worthy packing
Application Chemotherapy drug
Material Safety Data Sheet
Available on request
Availability For your requirements of evaluation, Pilots and Commercial procurement
Drug Master File Open part DMF available, DMF in CTD Format can be made available
Back to Previous Page Click here to Inquire
Are you looking for Dacarbazine Intermediates ? Please click here to browse through the list of Dacarbazine Intermediates available with us.
Advertisement
NOTE: 
  • Manus Aktteva Biopharma LLP, India is successfully representing suppliers, manufacturers from INDIA, suppliers, manufacturers from CHINA, and fulfilling the requirements of buyers from EUROPE, USA, South America, Japan, Korea, Taiwan, Australia, & middle-east.
       Keywords: New Molecules, patents, R&D, cas, cas number, product, supplier, suppliers, vendor, vendors, price, prices, api, apis, active pharmaceutical ingredient, ingredients, importer, exporter, distributor, import, export, sale, producer, manufacturer, synthesizer, synthesis, gmp, cgmp, fda, dmf, cgmp, cos, inventory, stock, prompt shipment, compounding, compound, research, development, patent, r and d, pharma
  • Please note that products falling in to controlled substance category shall be exported directly from the manufacturer principals only against receipt of original import permission issued by concerned authorities of the importing country.
PATENTS: 
  • => Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
        => Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1)
© 2018 MANUS AKTTEVA  All rights reserved..
Payment Procedure